The Scientist : Ritalin gets vote of approval in the UK [9/11/2000]

Front Cover

Advertisement

Front Cover

Survey Series

The Scientist Daily

Science headlines delivered daily.
Register today.

For Advertisers

Ritalin gets vote of approval in the UK

Email: Susan Mayor - Susan@Mayor.dircon.co.uk
News from The Scientist 2000, 1(1):20001109-03

9 November 2000

LONDON The UK's National Institute for Clinical Excellence (NICE) — which produces guidance for the National Health Service (NHS) on medicines, on the basis of clinical and cost effectiveness — has recommended that the use of methylphenidate (Ritalin/Equasyn) is appropriate for the treatment of severe Attention Deficit/Hyperactivity Disorder (ADHD). But it has cautioned that the amphetamine should only be prescribed after diagnosis of ADHD by a specialist and as part of a comprehensive treatment programme, with regular monitoring.


	The article you are attempting to read is Premium content which is only available to our online subscribers.

Subscribing to The Scientist is easy and inexpensive.

And you can choose from many options. Try us out with an online day pass starting at only $4.95. Or, get it all with unlimited online access to The Scientist Archive and door-to-door delivery of our monthly print magazine.


	The Scientist also offers site licenses to institutions and organizations. When your librarian adds The Scientist to the library's collection, you can get unlimited online access through your place of work or study. Recommend The Scientist today